These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 23931188)

  • 1. Re: Evaluation of acute toxicity and symptoms palliation in a hypofractionated weekly schedule of external radiotherapy for elderly patients with muscular invasive bladder cancer.
    Griebling T
    J Urol; 2013 Sep; 190(3):865-6. PubMed ID: 23931188
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of acute toxicity and symptoms palliation in a hypofractionated weekly schedule of external radiotherapy for elderly patients with muscular invasive bladder cancer.
    Kouloulias V; Tolia M; Kolliarakis N; Siatelis A; Kelekis N
    Int Braz J Urol; 2013; 39(1):77-82. PubMed ID: 23489500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of efficacy and toxicity in two different hypofractionated 3D-conformal external beam radiotherapy schedules in localised muscle invasive bladder cancer.
    Kouloulias V; Mosa E; Tolia M; Kantzou I; Koliarakis N; Platoni K; Georgakopoulos I; Siatelis A; Sarris G; Beli I; Chrisofos M; Kelekis N
    J BUON; 2013; 18(4):942-8. PubMed ID: 24344021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A weekly hypofractionated radiotherapeutic schedule for bladder carcinoma in elderly patients: local response, acute and late toxicity, dosimetric parameters and pain relief.
    Zygogianni A; Kouloulias V; Armpilia C; Antypas C; Kantzou I; Balafouta M; Kyrgias G; Sarris G; Kelekis N; Kouvaris J
    J BUON; 2013; 18(2):407-12. PubMed ID: 23818353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical results of conformal versus intensity-modulated radiotherapy using a focal simultaneous boost for muscle-invasive bladder cancer in elderly or medically unfit patients.
    Lutkenhaus LJ; van Os RM; Bel A; Hulshof MC
    Radiat Oncol; 2016 Mar; 11():45. PubMed ID: 26993980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypofractionated palliative radiotherapy for bladder cancer.
    Dirix P; Vingerhoedt S; Joniau S; Van Cleynenbreugel B; Haustermans K
    Support Care Cancer; 2016 Jan; 24(1):181-186. PubMed ID: 25975677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment margins and treatment fractionation in conformal radiotherapy of muscle-invading urinary bladder cancer.
    Muren LP; Redpath AT; McLaren DB
    Radiother Oncol; 2004 Apr; 71(1):65-71. PubMed ID: 15066297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypofractionated Dose Escalated 3D Conformal Radiotherapy for Prostate Cancer: Outcomes from a Mono-Institutional Phase II Study.
    Tramacere F; Arcangeli S; Pignatelli A; Castagna R; Portaluri M
    Anticancer Res; 2015 May; 35(5):3049-54. PubMed ID: 25964594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of morbidity following conformal versus intensity-modulated radiotherapy for urinary bladder cancer.
    Søndergaard J; Holmberg M; Jakobsen AR; Agerbæk M; Muren LP; Høyer M
    Acta Oncol; 2014 Oct; 53(10):1321-8. PubMed ID: 24980045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute toxicity of image-guided hypofractionated radiotherapy for prostate cancer: nonrandomized comparison with conventional fractionation.
    Jereczek-Fossa BA; Zerini D; Fodor C; Santoro L; Cambria R; Garibaldi C; Tagaste B; Vavassori A; Cattani F; Alterio D; Gherardi F; Serafini F; Rocco B; Musi G; De Cobelli O; Orecchia R
    Urol Oncol; 2011; 29(5):523-32. PubMed ID: 20005749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidental Dose to Pelvic Nodes in Bladder-Only Radiotherapy: Is It Clinically Relevant?
    Lewis S; Murthy V; Mahantshetty U; Shrivastava SK
    Technol Cancer Res Treat; 2017 Jun; 16(3):382-387. PubMed ID: 28168933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancer.
    Arcangeli G; Fowler J; Gomellini S; Arcangeli S; Saracino B; Petrongari MG; Benassi M; Strigari L
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1013-21. PubMed ID: 20447774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-course accelerated radiotherapy in palliative treatment of advanced pelvic malignancies: a phase I study.
    Caravatta L; Padula GD; Macchia G; Ferrandina G; Bonomo P; Deodato F; Massaccesi M; Mignogna S; Tambaro R; Rossi M; Flocco M; Scapati A; Scambia G; Pacelli F; Valentini V; Cellini N; Morganti AG
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e627-31. PubMed ID: 22580117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and dosimetric predictors of acute toxicity after a 4-week hypofractionated external beam radiotherapy regimen for prostate cancer: results from a multicentric prospective trial.
    Arcangeli S; Strigari L; Soete G; De Meerleer G; Gomellini S; Fonteyne V; Storme G; Arcangeli G
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):39-45. PubMed ID: 18538488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of invasive bladder cancer with conformal hypofractionated accelerated radiotherapy and amifostine (HypoARC).
    Panteliadou M; Giatromanolaki A; Touloupidis S; Destouni E; Tsoutsou PG; Pantelis P; Abatzoglou I; Sismanidou K; Koukourakis MI
    Urol Oncol; 2012; 30(6):813-20. PubMed ID: 21163674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofractionated radiotherapy with or without IGRT in prostate cancer: preliminary report of acute toxicity.
    Valeriani M; Monaco F; Osti MF; DE Sanctis V; Minniti G; Enrici RM
    Anticancer Res; 2011 Oct; 31(10):3555-8. PubMed ID: 21965777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Offline adaptive radiotherapy for bladder cancer using cone beam computed tomography.
    Foroudi F; Wong J; Haworth A; Baille A; McAlpine J; Rolfo A; Kron T; Roxby P; Paneghel A; Williams S; Duchesne G; Tai KH
    J Med Imaging Radiat Oncol; 2009 Apr; 53(2):226-33. PubMed ID: 19527372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D-conformal hypofractionated radiotherapy for prostate cancer with daily transabdominal ultrasonography prostate localization: toxicity and outcome of a pilot study.
    Zerini D; Jereczek-Fossa BA; Vavassori A; Bossi-Zanetti I; Mauro R; Ivaldi GB; Trovò M; Cambria R; Garibaldi C; Cattani F; Orecchia R
    Tumori; 2010; 96(6):941-6. PubMed ID: 21388056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute toxicity after hypofractionated conformal radiotherapy for localized prostate cancer: nonrandomized contemporary comparison with standard fractionation.
    Leborgne F; Fowler J
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):770-6. PubMed ID: 18375075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very elderly (>80 years), frail patients with muscle-invasive bladder cancer and comorbidities: is curative irradiation feasible?
    Santacaterina A; Platania A; Palazzolo C; Spatola C; Acquaviva G; Crispi M; Privitera G; Settineri N; Pergolizzi S
    Tumori; 2015; 101(6):609-13. PubMed ID: 25983093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.